Bengaluru, Jan. 8 -- The shares of this research-based biotechnology company are in focus after it announced a key business trial, which it developed along with ICMR. In this article, we will dive more into the details of it.

With a market capitalisation of Rs 2,534 crore, the shares of Panacea Biotec Ltd reached a day's high of Rs 422.30 per share, up 9 percent from its previous day's closing price of Rs 383.70 per share. Over the past five years, the stock has delivered a muted return of 75 percent, underperforming NIFTY 50's return of 81 percent.

About the Announcement

Panacea Biotec, through a stock exchange filing, announced that it has completed the enrollment phase (process of selecting and registering people for the study) for ...